Pfizer Products Inc has received an Indian Patent No. 201 982 (the ‘982 patent) titled Ziprasidone suspension against its application number 472/MUM/2000 filed May 23, 2000. The ‘982 patent claims its priority from US Provisional Application No. 60/136,268 filed May 27, 1999 against which the U.S. 7,175,855 (the ‘855 patent) is issued on February 13, 2007. The ‘855 patent is currently listed with Orange Book for Ziprasidone Suspension oral solution marketed under the brand name Geodon. The ‘855 patent is directed to a composition comprising ziprasidone hydrochloride, water, polysorbate 80, xanthan gum, and colloidal silicon dioxide.
No comments:
Post a Comment